Trevi Therapeutics, Inc. Common Stock (NASDAQ: TRVI) last traded at $13.19, up 2.85% on the session. The quote above updates while this page is open; the figures below are drawn from Trevi Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Trevi Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TRVI. Its market capitalisation is $1.88 billion.
Valuation measures for Trevi Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.88B |
|---|---|
| Enterprise value | $1.83B |
| Price / book | 5.85 |
| Beta | 1.10 |
Trailing-twelve-month figures tagged in Trevi Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$51.11M |
| EPS (TTM) | -$0.340 |
|---|
| Return on equity | -15.90% |
|---|
| Cash | $54.30M |
|---|
Range and volume for TRVI over the past 52 weeks.
| 52-week high | $20.22 |
|---|---|
| 52-week low | $9.28 |
| Volume | 5.03M |
| Average volume | 2.07M |
| Previous close | $12.83 |
Invest a chosen dollar amount in Trevi Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TRVI.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.